News
We expect Dynatrace to generate strong free cash flow margins as it increases its operating leverage while driving its top line forward. We see this trend as typical in the high-growth software space ...
The most recent development is that prosecutors announced this week they are reinstating special circumstances enhancements ...
Good afternoon and welcome to The Oncology Institute's First Quarter 2025 Earnings Conference Call. Today's call is being recorded and we have allocated 1 hour for prepared remarks and Q&A. At this ...
NIO stock offers value ahead of FQ1'25 earnings call, with strong EV sales and battery swaps driving growth. Explore risks & ...
Without clear insight into how AI models make decisions, businesses risk deploying tools that are unaccountable, biased or ...
Mr Skills on MSN11h
Unleashing Power at Full Capacity: The Giant Wood Factory Cutting Solid Wood for Massive CreationsStep into the heart of a giant wood factory operating at full capacity, where solid timber is transformed into incredible creations with unmatched precision. This powerhouse of production is a marvel ...
Citing high costs, a decades-long timeframe, lack of implementation capacity and needless environmental damage, the Center for Biological Diversity today urged the U.S. Forest Service to immediately ...
Rodger Painter says in a commentary that Tongass pulp mills closed primarily due to tree farms in climates where forests grow ...
Codexis reiterated its full-year 2025 financial guidance originally issued on February 27, 2025, as follows: Total revenues are expected to be in the range of $64 million to $68 million.
BOSTON and LONDON, May 14, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported financial results and business highlights for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results